Prescription Digital Therapeutics: An Emerging Treatment Option for Negative Symptoms in Schizophrenia.
Biol Psychiatry
; 96(8): 659-665, 2024 Oct 15.
Article
em En
| MEDLINE
| ID: mdl-38960019
ABSTRACT
Digital therapeutics-web-based programs, smartphone applications, and wearable devices designed to prevent, treat, or manage clinical conditions through software-driven, evidence-based intervention-can provide accessible alternatives and/or may supplement standard care for patients with serious mental illnesses, including schizophrenia. In this article, we provide a targeted summary of the rapidly growing field of digital therapeutics for schizophrenia and related serious mental illnesses. First, we define digital therapeutics. Then, we provide a brief summary of the emerging evidence of the efficacy of digital therapeutics for improving clinical outcomes, focusing on potential mechanisms of action for addressing some of the most challenging problems, including negative symptoms of psychosis. Our focus on these promising targets for digital therapeutics, including the latest in prescription models in the commercial space, highlights future directions for research and practice in this exciting field.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Esquizofrenia
/
Aplicativos Móveis
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article